And here's the kind of realistic scientific post we're missing by not having a COVID thread any more. This one's fairly upbeat and will hopefully dispel some fears that people might have about reinfection risks (I always tried to be balanced in my COVID posts).
Lots of concern being expressed about SARS-CoV-2 reinfection risks, especially with the recent case of an 89-year old patient being reinfected and dying. As per my note on this from about 6 weeks ago, linked below, reinfection was always expected to happen sooner or later and while any death is tragic, reinfection rates still look to be negligible and most who have been reinfected had minor cases and we're not seeing any unusual viral mutations going on out in the population.
The vast majority of people who have recovered from COVID should be immune to reinfection for at least 6-12 months (5-7 months demonstrated already) and likely longer, based on data we've seen so far and most experts expect that kind of immunity or longer for vaccines, although it's possible that an effective vaccine may need to be given every few years, which I'm sure most of us could live with.
As Derek Lowe said in his blog entry on this today - like he did yesterday about the holds on two vaccines and the Lilly antibody - don't panic. Here's an informative excerpt from his blog today...
𝗦𝗼 𝘁𝗵𝗲 𝘀𝗶𝘁𝘂𝗮𝘁𝗶𝗼𝗻, 𝗳𝗼𝗿 𝗻𝗼𝘄, 𝘀𝗲𝗲𝗺𝘀 𝘁𝗼 𝗯𝗲 𝘁𝗵𝗮𝘁 𝘆𝗲𝘀, 𝗿𝗲-𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲. 𝗕𝘂𝘁 𝗶𝘁’𝘀 𝗮𝗹𝘀𝗼 𝗾𝘂𝗶𝘁𝗲 𝗿𝗮𝗿𝗲. 𝗧𝗵𝗲𝗿𝗲 𝗮𝗿𝗲 𝘀𝘂𝗿𝗲𝗹𝘆 𝗰𝗮𝘀𝗲𝘀 𝘁𝗵𝗮𝘁 𝘄𝗲’𝘃𝗲 𝗺𝗶𝘀𝘀𝗲𝗱, 𝗯𝘂𝘁 𝗶𝘁’𝘀 𝗰𝗹𝗲𝗮𝗿𝗹𝘆 𝗻𝗼𝘁 𝘀𝗼𝗺𝗲𝘁𝗵𝗶𝗻𝗴 𝘁𝗵𝗮𝘁 𝗶𝘀 𝗵𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗺𝘂𝗰𝗵. 𝗪𝗲’𝗿𝗲 𝗱𝗲𝗮𝗹𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗳𝗮𝗰𝘁 𝘁𝗵𝗮𝘁 𝘁𝗵𝗲 𝗵𝘂𝗺𝗮𝗻 𝗶𝗺𝗺𝘂𝗻𝗲 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲 𝗶𝘀 𝗵𝘂𝗴𝗲𝗹𝘆 𝘃𝗮𝗿𝗶𝗮𝗯𝗹𝗲 𝗳𝗿𝗼𝗺 𝗽𝗲𝗿𝘀𝗼𝗻 𝘁𝗼 𝗽𝗲𝗿𝘀𝗼𝗻 – 𝘁𝗵𝗮𝘁’𝘀 𝗼𝗻𝗲 𝗼𝗳 𝗶𝘁𝘀 𝗸𝗲𝘆 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝘀. 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮𝗿𝗲 𝗴𝗼𝗶𝗻𝗴 𝘁𝗼 𝗿𝗮𝗶𝘀𝗲 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗹𝗲𝘃𝗲𝗹𝘀 𝗼𝗳 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝗼𝗳 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 𝘁𝗼 𝗮 𝗰𝗼𝗿𝗼𝗻𝗮𝘃𝗶𝗿𝘂𝘀 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝘁𝗵𝗮𝘁’𝘀 𝗮 𝗯𝗶𝗴 𝗿𝗲𝗮𝘀𝗼𝗻 𝘄𝗵𝘆 𝘁𝗵𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗰𝗼𝘂𝗿𝘀𝗲 𝗼𝗳 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗶𝘀 𝘀𝗼 𝘃𝗮𝗿𝗶𝗮𝗯𝗹𝗲. 𝗘𝘃𝗲𝗻 𝗶𝗻 𝘁𝗵𝗲𝘀𝗲 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗲𝗱 𝗿𝗲𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗰𝗮𝘀𝗲𝘀, 𝘄𝗲 𝗱𝗼𝗻’𝘁 𝗸𝗻𝗼𝘄 𝘁𝗵𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀 𝗮𝗯𝗼𝘂𝘁 𝘄𝗵𝗮𝘁 𝘁𝗵𝗲𝗶𝗿 𝗳𝗶𝗿𝘀𝘁 𝗶𝗺𝗺𝘂𝗻𝗲 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲𝘀 𝘄𝗲𝗿𝗲 𝗹𝗶𝗸𝗲 (𝘁𝗵𝗲𝗿𝗲 𝘄𝗮𝘀 𝗻𝗼 𝗿𝗲𝗮𝘀𝗼𝗻 𝘁𝗼 𝗽𝗿𝗼𝗳𝗶𝗹𝗲 𝘁𝗵𝗲𝘀𝗲 𝗽𝗲𝗼𝗽𝗹𝗲 𝗶𝗻 𝘀𝘂𝗰𝗵 𝗱𝗲𝘁𝗮𝗶𝗹 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝘁𝗶𝗺𝗲!)
𝗠𝗼𝘃𝗶𝗻𝗴 𝗯𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗮𝘁, 𝗜 𝘄𝗼𝘂𝗹𝗱 𝘀𝘂𝘀𝗽𝗲𝗰𝘁 𝘁𝗵𝗮𝘁 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻, 𝘄𝗵𝗶𝗰𝗵 𝗿𝗮𝗶𝘀𝗲𝘀 𝗻𝗲𝘂𝘁𝗿𝗮𝗹𝗶𝘇𝗶𝗻𝗴 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗦𝗽𝗶𝗸𝗲 𝗽𝗿𝗼𝘁𝗲𝗶𝗻, 𝘄𝗶𝗹𝗹 𝗽𝗿𝗼𝘃𝗶𝗱𝗲 𝗮 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗮𝘁 𝗶𝘀 𝗲𝘃𝗲𝗻 𝗹𝗲𝘀𝘀 𝘀𝘂𝘀𝗰𝗲𝗽𝘁𝗶𝗯𝗹𝗲 𝘁𝗼 𝗿𝗲-𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝘁𝗵𝗮𝗻 𝘄𝗲 𝗵𝗮𝘃𝗲 𝗶𝗻 𝘁𝗵𝗲 𝘄𝗶𝗹𝗱-𝘁𝘆𝗽𝗲-𝗿𝗲𝗰𝗼𝘃𝗲𝗿𝗲𝗱 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗻𝗼𝘄, 𝗴𝗶𝘃𝗲𝗻 𝘁𝗵𝗮𝘁 𝘁𝗵𝗿𝗲𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗳𝗶𝘃𝗲 𝗰𝗮𝘀𝗲𝘀 𝘄𝗲 𝗵𝗮𝘃𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀 𝗼𝗳 𝗱𝗶𝗱 𝗻𝗼𝘁 𝗵𝗮𝘃𝗲 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗦𝗽𝗶𝗸𝗲 𝗿𝗲𝗴𝗶𝗼𝗻 𝗮𝘁 𝗮𝗹𝗹. 𝗡𝗼𝘄, 𝘄𝗲 𝗱𝗼𝗻’𝘁 𝗸𝗻𝗼𝘄 𝗵𝗼𝘄 𝗹𝗼𝗻𝗴 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗽𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝘄𝗶𝗹𝗹 𝗹𝗮𝘀𝘁, 𝗼𝗿 𝗵𝗼𝘄 𝘃𝗮𝗿𝗶𝗮𝗯𝗹𝗲 𝗶𝘁 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗶𝗻 𝗮 𝗯𝗿𝗼𝗮𝗱 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 – 𝘄𝗲’𝗿𝗲 𝗼𝘂𝘁 𝘁𝗵𝗲𝗿𝗲 𝗴𝗲𝘁𝘁𝗶𝗻𝗴 𝘁𝗵𝗼𝘀𝗲 𝗱𝗮𝘁𝗮 𝗻𝗼𝘄 – 𝗯𝘂𝘁 𝗳𝗿𝗼𝗺 𝘄𝗵𝗮𝘁 𝘄𝗲’𝗿𝗲 𝘀𝗲𝗲𝗶𝗻𝗴, 𝗜 𝘁𝗵𝗶𝗻𝗸 𝘁𝗵𝗲 𝗽𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀 𝗮𝗿𝗲 𝗴𝗼𝗼𝗱. 𝗡𝗼 𝗽𝗮𝗻𝗶𝗰 𝗻𝗲𝗰𝗲𝘀𝘀𝗮𝗿𝘆 𝗳𝗼𝗿 𝗻𝗼𝘄.
https://blogs.sciencemag.org/pipeline/archives/2020/10/14/immunity-and-re-infection
https://rutgers.forums.rivals.com/t...es-interventions-and-more.198855/post-4680066
